Editing
293E Protein Production
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== <br>'''Small-Scale Transfection in Six-Well Plates or 125-mL Shake Flasks using Branched PEI''' == INTRODUCTION Fast and efficient production of recombinant proteins (r-proteins) remains a major challenge for the academic and biopharmaceutical communities. Pure r-proteins are often required in large amounts (hundreds of milligrams to gram quantities) when being developed as biotherapeutics, or in smaller quantities (milligrams) for high-throughput screening campaigns and structural or functional studies. Mammalian cells are often preferred over prokaryotic systems when expressing cDNAs of mammalian origin due to their superior capability to conduct elaborate post-translational modifications. Large-scale transfection of mammalian cells is now establishing itself as a “must-have” technology in the scientific community, as it allows the production of milligram to gram quantities of r-proteins within a few days after cDNA cloning into the appropriate expression vector. Although calcium-mediated large-scale transfection is very effective, polyethylenimine (PEI) is much easier to use: It binds to and precipitates DNA efficiently and the resulting DNA-PEI complexes are suitable for efficient transfection of mammalian cells. In particular, the branched isoform of PEI works well for adherent cells, as it promotes their attachment to the plastic surface. It is thus very useful in experiments requiring multiple medium exchanges or washing steps following transfection. Also, when used in conjunction with six-well CellBIND plates, branched PEI can be used to adhere transfected cells when establishing stable cell lines. This protocol describes the steps needed for successful transfection of HEK293 cells adapted to serum-supplemented or serum-free medium in adherent culture using branched PEI.<br><br> === <br>MATERIALS<br> === <br>'''Reagents''' 293E cells, maintenance (in T-flask or shake flask) See Culture of HEK293-EBNA1 Cells for Production of Recombinant Proteins (this issue) for preparation. The presence of G418 does not interfere with transfection. Calf serum, cosmic (HyClone) Thaw the frozen serum thoroughly at 37°C. Heat-inactivate for 30 min in a 56°C bath, swirling the bottle occasionally for thorough heat distribution. Store aliquots at -20°C. G418, 50 mg/mL stock solution (Invitrogen) LC-SFM medium (Invitrogen) Supplement with 1% (v/v) heat-inactivated calf serum and 50 μg/mL G418 prior to use. cautionPhosphate-buffered saline (PBS) cautionPolyethyleneimine (PEI), branched (1 mg/mL) Plasmid DNA of interest, purified Prepare using CSH Protocols articles Preparation of Plasmid DNA by Alkaline Lysis with SDS: Maxipreparation or Preparation of Plasmid DNA by Large-Scale Boiling Lysis. Plasmid, fluorescent protein-expressing (optional; see Step 8) Adding a plasmid encoding a fluorescent protein (e.g., green fluorescent protein [GFP]) to 5% in the transfection mixture does not significantly alter expression of the gene of interest and allows visual (or quantitative, if using flow cytometry) confirmation of transfection efficiency. A few GFP-positive cells can be detected as early as 3-4 h post-transfection using a fluorescence microscope. Pluronic F-68, 10% stock solution (w/v) (Invitrogen) TN1 medium, prewarmed (e.g., FreeStyle medium or LC-SFM containing 20% [w/v] Tryptone N1 [Organotechnie]) (optional; see Step 13) Supplement with 0.1% (w/v) Pluronic F-68 and filter-sterilize prior to use.<br>'''Equipment''' Containers, plastic (e.g., Tupperware) Hemocytometer Incubator preset to 37°C, humidified, 5% CO2 Microscope, fluorescence (optional; see Step 8) Paper towels Plates, six-well, disposable (CellBIND; Corning) Tubes, 15-mL Vortex mixer<br> === <br><br>METHOD === <br> Although the protocol described here uses a DNA:PEI ratio of 1.5:2, the ratio selected for production should be determined by testing various ratios in six-well plate experiments. These small-scale tests must include regular samplings to determine the optimal harvest periods. 1. Warm the LC-SFM culture medium to 37°C. 2. Remove the cell maintenance T-flask from the incubator. Dislodge the cells by gently tapping the side of the flask This is not necessary if the maintenance cultures are in shake flasks. 3. Remove a cell aliquot to determine cell density and viability using a hemocytometer. 4. In a 15-mL tube, dilute the cells to 2.5 × 105 cells/mL in a volume of 12 mL of medium. This can be scaled down to 1 mL in 12-well plates. 5. Add 1.8 mL of cells to each of the six wells. Transfer to the incubator. Culture for 24 h. To minimize medium evaporation, put the plates in a plastic container lined with a wet paper towel to preserve humidity. “Trap” some CO2 in the container before closing the lid. 6. On the day of transfection, warm the PBS to 25°C-37°C. Thaw the DNA and PEI. 7. Aliquot 100 μL of PBS to each of six 1.5-mL tubes. 8. Add 3 μg of DNA to each tube. Vortex. To evaluate transfection efficiency, add a GFP expression plasmid at 5% of the final DNA content used. A reasonable indicator of successful transfection is when the percentage of GFP-positive cells is between 30% and 50% by 48-72 h post-transfection. 9. To another 1.5-mL tube, add 672 μL of PBS. Add 28 μL of branched PEI solution. Vortex. 10. Add 100 μL of PEI solution to each DNA-containing tube. Vortex immediately (three times, 3 sec each) after PEI addition. Compare different DNA:PEI ratios to see whether different lots and/or production batches affect transfection efficiency and productivity. Each new PEI preparation must be tested. 11. Incubate for 15 min at room temperature. 12. Remove the six-well plate from the incubator. Add the DNA/PEI mixture to each well and swirl the plate. Return the plate to the incubator. 13. For secreted protein production, add 50 μL of prewarmed TN1 medium at 24-48 h post-transfection to each of the six wells. Return the culture to the incubator. The final TN1 concentration in the culture(s) should be 0.5% (w/v). TN1 supplementation is not necessary for intracellular protein production. 14. Harvest the r-proteins: For intracellular r-proteins i. Harvest the cells at 48-72 h post-transfection. Establish the best harvesting time by performing an expression kinetics study. For secreted r-proteins ii. Harvest the supernatants between 96 and 168 h post-transfection as long as the culture viability is high and the product titer is increasing. Because culture viability decreases with time, it is important to harvest when the viability is relatively high (i.e., greater than 75%) to protect the r-protein from proteolytic degradation. See Troubleshooting. <br>TROUBLESHOOTING Problem: The transfection does not work. [Step 14] Solution: Consider the following: 1. Make sure the cells are in exponential growth phase for transfections. If the culture grows to higher-than-prescribed transfection densities, medium nutrient depletion and metabolic by-products will compromise the transfection. 2. Anti-clumping agents such as dextran sulfate can inhibit transfection. 3. DNA plasmid quality may be inadequate. Check for contaminants by A260/A280 ratio readings; acceptable values range between 1.80 and 1.95. In addition, the DNA plasmid can be digested and run on an agarose gel to verify its integrity (it should be mostly in a supercoiled form) and/or to detect RNA contamination. 4. Monitor cell line productivity occasionally by transfecting the cells with an easily measured protein such as secreted alkaline phosphatase or GFP. Low transfection efficiencies are readily indicated when the percentage of GFP-positive cells is below 30% by 48 h post-transfection. Also, for each new medium or reagent lot, monitor transfection efficiencies using six-well plate assays. <br>
Summary:
Please note that all contributions to ELN may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
ELN:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
View history
More
Search
Navigation
Category:
Main page
To Do
Tasks
My ELN
Weekly Reports
Buffer Recipe
SOP
Protocols
Inventories
Projects
Products
Customers
Contacts
Suppliers
Vectors
Vector Map
Clones
Cloning
Sequencing
NGS
Protein Expression
Purchaseing
QC
293 Expression
CHO Expression
Sf9 Expression
Protein Purification
Stem Cells
Cytokines
Protein Kinases
GPCR
Cell Lines
Competent Cells
Viral Proteins
VLP
Baculovirus
AAV
Adenovirus
Lentivirus
Virus Titering
Antibodies
Transfection
ELISA
qPCR RT-PCR
ImmunoAssay
Multiplex BioAssa
Lateral_Flow
Conjugation
Compounds Synthesis
BioEngineering
GenomeEngineering
Services
Software
Ideas
Links
Knowledgebase
Employees
Company
Tools
What links here
Related changes
Page information
Navigation
Special pages